Format

Send to

Choose Destination
Mucosal Immunol. 2015 Sep;8(5):969-978. doi: 10.1038/mi.2015.49. Epub 2015 Jun 17.

Regulatory immune cells in regulation of intestinal inflammatory response to microbiota.

Sun M#1, He C#1,2, Cong Y2,3, Liu Z1.

Author information

1
Department of Gastroenterology, Institute for Intestinal Diseases, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.
2
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
3
Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.
#
Contributed equally

Abstract

The intestinal lumen harbors nearly 100 trillion commensal bacteria that exert crucial function for health. An elaborate balance between immune responses and tolerance to intestinal microbiota is required to maintain intestinal homeostasis. This process depends on diverse regulatory mechanisms, including both innate and adaptive immunity. Dysregulation of the homeostasis between intestinal immune systems and microbiota has been shown to be associated with the development of inflammatory bowel diseases (IBD) in genetically susceptible populations. In this review, we discuss the recent progress reported in studies of distinct types of regulatory immune cells in the gut, including intestinal intraepithelial lymphocytes, Foxp3(+) regulatory T cells, regulatory B cells, alternatively activated macrophages, dendritic cells, and innate lymphoid cells, and how dysfunction of this immune regulatory system contributes to intestinal diseases such as IBD. Moreover, we discuss the manipulation of these regulatory immune cells as a potential therapeutic method for management of intestinal inflammatory disorders.

PMID:
26080708
PMCID:
PMC4540654
DOI:
10.1038/mi.2015.49
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center